GIEBELSTADT, Germany - BAVARIA Yachtbau GmbH ("BAVARIA") today announced that Anchorage Advisors, L.L.C. ("Anchorage") and Oaktree Capital Management ("Oaktree"), who collectively control approximately 95 percent of BAVARIA's EUR960 million debt facilities, have signed a binding agreement to restructure the company's balance sheet. The restructuring will create an industry leading balance sheet through a capital injection of EUR55 million in cash and the write-down of over 90 percent of the senior and junior debt tranches. Anchorage and Oaktree have been working collaboratively with Bain Capital ("Bain"), and look forward to Bain's continued involvement upon consummation of the agreement, which is subject to regulatory and anti-trust clearance.

WASHINGTON - Riki Ellison, Chairman and Founder of the Missile Defense Advocacy Alliance (MDAA), www.missiledefenseadvocacy.org, has analyzed the current situation with Iran and given his comments below. Ellison is one of the top lay experts in missile defense in the world:

Bharatbook.com included a new report on "Retail Industry in North America - IT Market Assessment" highlights the market trends, growth drivers and restraints in the Retail Industry in North America.

MUZEO UNVEILS OPULENT “TREASURES OF NAPOLÉON” OCT. 11, 2009 New Exhibition Makes Only West Coast Stop; Showcases Over 300 Antiquities From the Personal Effects of One of the World’s Most Important Historical Figures

Stem Cell Therapeutics Markets report ( https://www.bharatbook.com/Market-Research-Reports/Stem-Cell-Therapeutics-Markets.html ) gives Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.